Novel Approach To Reduce the Hepatitis C Virus (HCV) Window Period: Clinical Evaluation of a New Enzyme-Linked Immunosorbent Assay for HCV Core Antigen
The window period in hepatitis C virus (HCV) infection is still a major problem in ensuring blood safety. HCV RNA detection by nucleic acid amplification technology-based tests has contributed to reduce the infectivity of blood products, but it is expensive, time-consuming and affected by a high pre...
Gespeichert in:
| Veröffentlicht in: | J Clin Microbiol |
|---|---|
| Hauptverfasser: | , , , , , , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
American Society for Microbiology (ASM)
2001
|
| Schlagworte: | |
| Online-Zugang: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC88305/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/11526137/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/JCM.39.9.3110-3114.2001 |
| Tags: |
Keine Tags, Fügen Sie das erste Tag hinzu!
|
